1. Guidelines of care for the management of psoriasis and psoriatic arthritis: section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics;Menter;J Am Acad Dermatol,2008
2. Nast A, Gisondi P, Ormerod AD, et al. European S3-Guidelines on the systemic treatment of psoriasis vulgaris. Update 2015 EDF in cooperation with EADV and IPC. Available from: http://onlinelibrary.wiley.com/store/10.1111/jdv.13354/asset/supinfo/jdv13354-sup-0001-DataS1.pdf?v=1&s=b537740852c89200b2131f209dbd2a0af20ead88. Accessed February 15, 2017.
3. Canadian guidelines for the management of plaque psoriasis: overview;Papp;J Cutan Med Surg,2011
4. The cost of biologics for psoriasis is increasing;Cheng;Drugs Context,2014
5. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, and Center for Biologics Evaluation and Research. Quality considerations in demonstrating biosimilarity of a therapeutic protein product to a reference product. Guidance for industry. Available from: http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm291134.pdf. Accessed November 18, 2016.